Correlation Between ANA Holdings and Regeneron Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ANA Holdings and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANA Holdings and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANA Holdings and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on ANA Holdings and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANA Holdings with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANA Holdings and Regeneron Pharmaceuticals.

Diversification Opportunities for ANA Holdings and Regeneron Pharmaceuticals

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between ALNPY and Regeneron is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding ANA Holdings Inc and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and ANA Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANA Holdings are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of ANA Holdings i.e., ANA Holdings and Regeneron Pharmaceuticals go up and down completely randomly.

Pair Corralation between ANA Holdings and Regeneron Pharmaceuticals

Assuming the 90 days horizon ANA Holdings is expected to generate 1.38 times more return on investment than Regeneron Pharmaceuticals. However, ANA Holdings is 1.38 times more volatile than Regeneron Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest  402.00  in ANA Holdings on September 2, 2022 and sell it today you would earn a total of  24.00  from holding ANA Holdings or generate 5.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

ANA Holdings Inc  vs.  Regeneron Pharmaceuticals

 Performance (%) 
       Timeline  
ANA Holdings 
ALNPY Performance
9 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in ANA Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, ANA Holdings showed solid returns over the last few months and may actually be approaching a breakup point.

ALNPY Price Channel

Regeneron Pharmaceuticals 
Regeneron Performance
12 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Regeneron Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Regeneron Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Regeneron Price Channel

ANA Holdings and Regeneron Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ANA Holdings and Regeneron Pharmaceuticals

The main advantage of trading using opposite ANA Holdings and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANA Holdings position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.
ANA Holdings vs. Meta Materials
The idea behind ANA Holdings and Regeneron Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Regeneron Pharmaceuticals vs. Walmart
Regeneron Pharmaceuticals vs. Meta Materials
Regeneron Pharmaceuticals vs. Dupont De Nemours
Regeneron Pharmaceuticals vs. Verizon Communications
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go